Q4 2022 revenue growth of 9% and FY 2022 revenue growth of 5% over the corresponding periods of 2021 PLEASANTON, Calif., Feb. 15, 2023 /PRNewswire/ -- 10x Genomics, Inc. (TXG) today reported financial ...

Good afternoon. Thank you for attending today's 10x Genomics Fourth Quarter and Full Year 2022 Earnings Conference Call. My name is Bethany, and I will be the moderator for today's call. All lines ...

View original content to download multimedia:https://www.prnewswire.com/news-releases/10x-genomics-reports-third-quarter-2022-financial-results-301666704.html SOURCE ...

It's not so simple to turn $100 into $1,000 in one year. At least not in the stock market. Investors looking for that kind of gain typically speculate in riskier investments such as cryptocurrency.

PLEASANTON, Calif., Jan. 26, 2022 /PRNewswire/ -- 10x Genomics (Nasdaq: TXG) today announced it will report financial results for the fourth quarter and full year ended December 31, 2021 after market ...

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. Sign up for our newsletter to get the latest on the transformative ...

With so many fascinating developments that occurred in the market during 2021, it’s extremely difficult to pick out just one. Certainly, the rise of meme stocks may have forever changed how Wall ...

Pagaya will go public through a SPAC merger in early 2022. The AI-based lending platform is a competitor in Upstart's industry, with a twist. The company has a massive addressable market and is just ...

"The clear highlight of 2022 was the velocity of our innovation engine as our team delivered catalytic launches across all three platforms," said Serge Saxonov, Co-founder and CEO of 10x Genomics. "We ...